It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for ...
Independent Health Association of Buffalo, which operates two Medicare Advantage plans, will pay up to $98 million. Betsy ...
Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.
The proposal aimed to streamline how schools bill Medicaid for the mental health and medical services they provide to ...
Ignore the winds of political change swirling around you, and instead focus on keeping your own matters in order.
The Centers for Medicare & Medicaid Services (CMS) has named 14 states plus the District of Columbia to participate in the ...
Michael Brier, 62, was accysed of defrauding Medicare, Medicaid, and other health insurers out of millions of dollars by ...
The Centers for Medicare & Medicaid Services Jan. 8 announced 23.6 million consumers have signed up for a 2025 Health ...
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback